Titan Biotech

{
  "main_header": {
    "sid": 779371,
    "name": "Titan Biotech",
    "stock_name": "Titan Biotech",
    "full_name": "Titan Biotech Ltd",
    "name_url": "stocks-analysis/titan-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,036.70",
    "chg": 36.6,
    "chgp": "3.66%",
    "dir": 1,
    "prev_price": "1,000.10",
    "mcapval": "853.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524717,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE150C01011",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "7.24 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/titan-biotech-779371-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Titan Biotech Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-ltd-is-rated-hold-by-marketsmojo-3818029",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/TitanBiotechLtd_mojoScore_3818029.png",
        "date": "2026-02-03 10:10:04",
        "description": "Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Titan Biotech Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-ltd-is-rated-hold-3801541",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TitanBiotechLtd_mojoScore_3801541.png",
        "date": "2026-01-23 10:10:03",
        "description": "Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Titan Biotech Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-ltd-is-rated-hold-3789855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TitanBiotechLtd_mojoScore_3789855.png",
        "date": "2026-01-12 10:10:03",
        "description": "Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 18 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3786349",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TitanBiotechLtd_technicaldot_3786349.png",
        "date": "2026-01-09 08:06:24",
        "description": "Titan Biotech Ltd, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 18 Sep 2025, the stock’s price action and technical indicators suggest a cautiously optimistic outlook amid mixed market conditions."
      },
      {
        "title": "Titan Biotech Ltd Technical Momentum Shifts Amid Strong Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-ltd-technical-momentum-shifts-amid-strong-returns-3782581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TitanBiotechLtd_technicaldot_3782581.png",
        "date": "2026-01-06 08:23:52",
        "description": "Titan Biotech Ltd, a key player in the Specialty Chemicals sector, has recently exhibited a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite mixed signals from various technical indicators, the stock’s price momentum remains robust, outperforming the broader market benchmarks over multiple timeframes."
      },
      {
        "title": "Titan Biotech Ltd Sees Bullish Momentum Shift Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-ltd-sees-bullish-momentum-shift-amid-technical-upgrades-3780936",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TitanBiotechLtd_technicaldot_3780936.png",
        "date": "2026-01-05 08:05:54",
        "description": "Titan Biotech Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by key indicator upgrades and a strong performance relative to the Sensex. The company’s recent technical parameter changes suggest improving investor sentiment and potential for further gains in the specialty chemicals sector."
      },
      {
        "title": "Titan Biotech Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-ltd-is-rated-hold-by-marketsmojo-3777524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/TitanBiotechLtd_mojoScore_3777524.png",
        "date": "2026-01-01 10:10:03",
        "description": "Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing."
      },
      {
        "title": "Titan Biotech Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/titan-biotech-upgraded-to-hold-by-marketsmojo-on-improving-fundamentals-3764895",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/TitanBiotech_mojoScore_3764895.png",
        "date": "2025-12-21 10:10:05",
        "description": "Titan Biotech, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows notable developments in the company’s quarterly performance and market returns, signalling a nuanced change in investor perception."
      },
      {
        "title": "Why is Titan Biotech falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-titan-biotech-fallingrising-3749451",
        "imagepath": "",
        "date": "2025-12-06 01:07:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Titan Biotech’s share price has been under pressure over the past week, declining by 3.89% while the Sensex remained virtually flat, gaining a marginal 0.01%. Over the last month, the stock’s decline has been more pronounced at 7.03%, contrasting with the Sensex’s 2.70% rise. This divergence highlights a period of underperformance for Titan Biotech in the short term, despite its impressive gains over longer horizons.</p>\n<p>Year-to-date, Titan Biotech has delivered a robust 28.47% return, significantly outpacing the Sensex’s 9.69%. Over one year, the stock’s 9.25% gain also surpasses the benchmark’s 4.83%. The company’s three- and five-year returns are particularly striking, with gains of 212.74% and 654.29% respectively, dwarfing the ..."
      }
    ],
    "total": 372,
    "sid": "779371",
    "stock_news_url": "https://www.marketsmojo.com/news/titan-biotech-779371"
  },
  "announcements": [
    {
      "caption": "Newspaper Advertisement Pertaining To Transfer Of Physical Shares Under Special Window",
      "datetime": "30-Jan-2026",
      "details": "Newspaper Advertisement submission for inviting claims or objection for transfer of physical Shares under Special Window",
      "source": "BSE"
    },
    {
      "caption": "Re-Lodgement Of Transfer Requests Of Physical Shares",
      "datetime": "15-Jan-2026",
      "details": "Please find attached herewith report for the month of December 2025 pertaining to re-lodgements of transfer of Physical Shares",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for quarter ended 31st December 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has announced <strong>2:10</strong> stock split, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Titan Biotech Ltd is Rated Hold by MarketsMOJO

2026-02-03 10:10:04

Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 September 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 03 February 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Titan Biotech Ltd is Rated Hold

2026-01-23 10:10:03

Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Titan Biotech Ltd is Rated Hold

2026-01-12 10:10:03

Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 18 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-01-09 08:06:24

Titan Biotech Ltd, a key player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 18 Sep 2025, the stock’s price action and technical indicators suggest a cautiously optimistic outlook amid mixed market conditions.

Read full news article

Titan Biotech Ltd Technical Momentum Shifts Amid Strong Returns

2026-01-06 08:23:52

Titan Biotech Ltd, a key player in the Specialty Chemicals sector, has recently exhibited a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite mixed signals from various technical indicators, the stock’s price momentum remains robust, outperforming the broader market benchmarks over multiple timeframes.

Read full news article

Titan Biotech Ltd Sees Bullish Momentum Shift Amid Technical Upgrades

2026-01-05 08:05:54

Titan Biotech Ltd has demonstrated a notable shift in price momentum, moving from a mildly bullish to a bullish technical trend, supported by key indicator upgrades and a strong performance relative to the Sensex. The company’s recent technical parameter changes suggest improving investor sentiment and potential for further gains in the specialty chemicals sector.

Read full news article

Titan Biotech Ltd is Rated Hold by MarketsMOJO

2026-01-01 10:10:03

Titan Biotech Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 January 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Read full news article

Titan Biotech Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Dynamics

2025-12-21 10:10:05

Titan Biotech, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment follows notable developments in the company’s quarterly performance and market returns, signalling a nuanced change in investor perception.

Read full news article

Why is Titan Biotech falling/rising?

2025-12-06 01:07:27

Recent Price Movement and Market Context

Titan Biotech’s share price has been under pressure over the past week, declining by 3.89% while the Sensex remained virtually flat, gaining a marginal 0.01%. Over the last month, the stock’s decline has been more pronounced at 7.03%, contrasting with the Sensex’s 2.70% rise. This divergence highlights a period of underperformance for Titan Biotech in the short term, despite its impressive gains over longer horizons.

Year-to-date, Titan Biotech has delivered a robust 28.47% return, significantly outpacing the Sensex’s 9.69%. Over one year, the stock’s 9.25% gain also surpasses the benchmark’s 4.83%. The company’s three- and five-year returns are particularly striking, with gains of 212.74% and 654.29% respectively, dwarfing the ...

Read full news article

View All News